Which does put 23andme's health results in this realm soneca described of "things that might be interesting, but can't be very actionable because they don't want to scare you by returning actually actionable information to you".
Then the FDA came down on them like a ton of bricks.
Now it sounds like they're reopening that door, slowly, step by step. I'm all for it.
So, that is an interesting and valid point. I've thought about it myself. Seems like these tests are something new, and it may take a while before the new thing is absorbed into the culture and it's treated the way it should. Yes, there is still the risk of misunderstanding the information you're getting.
There are also a few simple solutions - e.g. any doctor should be able to help you correctly integrate this information.
How do you know this is accurate?
https://mobile.nytimes.com/2013/12/31/science/i-had-my-dna-p...
>23andMe said my most elevated risks — about double the average for women of European ethnicity — were for psoriasis and rheumatoid arthritis, with my lifetime odds of getting the diseases at 20.2 percent and 8.2 percent. But according to Genetic Testing Laboratories, my lowest risks were for — you guessed it — psoriasis (2 percent) and rheumatoid arthritis (2.6 percent).
>In the case of Type 2 diabetes, inconsistencies on a semantic level masked similarities in the numbers. G.T.L. said my risk was “medium” at 10.3 percent, but 23andMe said my risk was “decreased” at 15.7 percent. In fact, both companies had calculated my odds to be roughly three-quarters of the average, but they used slightly different averages — and very different words — to interpret the numbers. In isolation, the first would have left me worried; the second, relieved.
I'm Canadian and have access to the full list of 23andme's health results. I actually found out that I have a recessive CF trait. Not 100% sure that its correct, but definitely something that I'm going to check out before having kids.
I'd much rather have known about that now, than after having a kid with CF.